Collaborate Corporation Limited (ASX:CL8) is pleased to provide an updated Investor Presentation which incorporates feedback from discussions with stockbroking firms and institutions, further detail on current business strategy and initiatives and full FY18 results.
Collaborate Corporation Limited (ASX:CL8) is pleased to confirm the despatch today of the prospectus as lodged with ASIC and ASX on 14 September 2018, including the entitlement and acceptance form, for the partially underwritten non-renounceable entitlement issue of shares to raise approximately $1.16 million before costs.
Collaborate Corporation Limited (ASX:CL8) is undertaking a non-renounceable entitlement issue to shareholders of up to 77,389,732 new fully paid ordinary shares at an issue price of $0.015 each to raise up to approximately $1,160,846, before costs. The Company lodged a prospectus for the Offer with ASIC and ASX on 14 September 2018.
As announced on 10 September 2018 Collaborate Corporation Limited is undertaking a 1:8 non-renounceable entitlement issue of approximately 77,389,732 fully paid ordinary shares to raise approximately $1,160,846.
Collaborate Corporation Limited (ASX:CL8) (Collaborate or the Company) is pleased to release its prospectus for the partially underwritten non-renounceable entitlement issue of shares to raise approximately $1.16 million before costs.
Collaborate Corporation Limited (ASX:CL8) is pleased to announce its proposal to undertake a partially underwritten non-renounceable pro rata entitlement offer of approximately 77,389,732 new Collaborate shares to raise approximately $1.16 million on the basis of 1 new Collaborate share for every 8 existing Collaborate shares held at an issue price of $0.015 per new Share.
Collaborate Corporation Limited (ASX:CL8) is pleased to provide an update on the Growth Opportunities first outlined on 30 April 2018 and updated in announcements released on 21 June and 31 July 2018.
